Close Menu

drug resistance

Merck will provide OpGen with access to its library of bacterial pathogens in order to support OpGen's development of rapid DNA tests and a pathogens database.

Called the Antimicrobial Resistance Diagnostic Challenge, the competition is a joint effort between the NIH and the HHS preparedness office.